文献速递血液透析通路

肱动脉-动脉人工血管环作为永久性血液透析通路的中期结局

Midterm outcomes of brachial arterio-arterial prosthetic loop as permanent hemodialysis access.
PubMed 文献 · J Vasc Surg · 2020-01-25

单中心前瞻性观察研究纳入89例肱动脉-动脉人工血管环(AAPL)手术,用于严格选择的终末期肾病患者。平均随访28.7±4.9个月,24个月一期、辅助一期和二期通畅率分别为62%±5.2%、71.2%±4.9%和89.6%±3.3%。结论认为AAPL可作为永久性透析通路的简单、安全、有效的替代选择,耐久性和并发症率可接受。

要点

  • 肱动脉AAPL在严格选择的终末期肾病患者中24个月二期通畅率达89.6%±3.3%。
  • 外周静脉耗竭是肱动脉AAPL最常见的适应证。
  • 需血管外科与透析人员协作管理以保障通路效果。

核心结论

  • 肱动脉AAPL可为严格选择的终末期肾病患者提供简单、安全、有效的永久性血液透析通路替代选择,耐久性和并发症率可接受。

研究设计与样本

  • 单中心前瞻性观察研究,2014年1月至2017年6月期间纳入89例肱动脉AAPL手术。

主要发现

  • 24个月一期、辅助一期和二期通畅率分别为62%±5.2%、71.2%±4.9%和89.6%±3.3%。
  • 外周静脉耗竭是肱动脉AAPL最常见的适应证。

关键数值与推荐

  • 24个月一期通畅率62%±5.2%,辅助一期通畅率71.2%±4.9%,二期通畅率89.6%±3.3%。

临床怎么用

  • 在严格选择的终末期肾病患者中,可考虑肱动脉AAPL作为永久性血液透析通路。
  • 因该通路规格独特,血管外科医师与透析工作人员必须协作管理。

局限性

  • 单中心前瞻性观察研究,样本量89例,随访至中期,非随机对照设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to report the midterm outcomes of the brachial arterio-arterial prosthetic loop (AAPL) as an alternative permanent vascular access in strictly selected patients with end-stage renal disease. METHODS: This single-center prospective observational study was conducted between January 2014 and June 2017 and included 89 brachial AAPL procedures. Primary, assisted primary, and secondary patency rates were calculated using Kaplan-Meier analysis. RESULTS: Exhausted peripheral veins were the most common indication for brachial AAPL. Patients were followed up for a mean period of 28.7 ± 4.9 months. Nineteen grafts developed thrombosis, 13 grafts developed pseudoaneurysms, 9 grafts developed hematoma, and 6 grafts were abandoned because of infection. The primary, assisted primary, and secondary patency rates were 62% ± 5.2%, 71.2% ± 4.9%, and 89.6% ± 3.3% at 24 months, respectively. CONCLUSIONS: Brachial AAPL can offer a simple, safe, and efficient alternative as a permanent hemodialysis access in a selected subset of end-stage renal disease patients, with acceptable durability and rate of complications. Because of its unique specifications, cooperation between vascular surgeons and dialysis staff is mandatory.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ali H, Elbadawy A, Saleh M, et al. Midterm outcomes of brachial arterio-arterial prosthetic loop as permanent hemodialysis access. J Vasc Surg. 2020. PMID: 31987667. doi:10.1016/j.jvs.2019.10.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。